Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
boston top stories
clinical trials
4
×
life sciences
national blog main
4
×
boston
fda
ipo
national top stories
san francisco blog main
san francisco top stories
new york blog main
new york top stories
renaissance capital
san francisco
480 biomedical
aligos therapeutics
antibiotics
arsenal medical
arvinas
astrazeneca
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
carbapenem-resistant enterobacteriaceae
cavion
celgene
cephalgia
chronic hepatitis b virus
chronic rhinosinusitis
colorectal cancer
What
way
4
×
ipo
biotechs
company
ipos
medicines
research
biotech
cancer
cancer’s
central
chose
close
cns
debut
developing
device
disease
disorder
drugs
emerged
firms
frontiers
kept
known
late
leads
life
lyra
make
maps
markets
medical
million
nervous
new
nose
noses
open
parlance
Language
unset
Current search:
way
×
" national blog main "
×
" clinical trials "
×
" boston blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way